# bit.bio: Research, Cambridge, United Kingdom

> bit.bio: bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom. Based in Cambridge, United Kingdom. Founded 2016.

Source: https://millionrounds.com/startup/bit-bio (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Research startup](https://millionrounds.com/companies)

# bit.bio

bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.

Funding reported Last round: Series C

Research Cambridge, United Kingdom

Company summary

- **Founded:** 2016 10 years old
- **Team:** 160 51 to 200 people
- **Funding reported:** 225M as listed, currency not stated
- **Last round:** Series C Jan 2026

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for bit.bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About bit.bio

bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.

Founded in 2016 by Dr. Mark Kotter, the company focuses on manufacturing human cells with high consistency and purity at an industrial scale. bit.bio aims to address the challenges in cell therapies and research by providing a reliable source of human cells, leveraging its proprietary opti-oxTM technology for precise cell programming. The company offers a range of services, including custom cell programming, large-scale cell manufacturing, and disease modeling support. Its product line, branded as ioCellsTM, features various pre-programmed human cells, such as neurons, immune cells, and muscle cells, designed for research and drug discovery. bit.bio serves a diverse clientele, including pharmaceutical companies, academic institutions, and firms involved in toxicology and regenerative medicine, positioning itself as a leader in the field of cell manufacturing.

## What company datasets say bit.bio raised

Funding, as reported

Reported in all **225M** in the source's currency

Rounds **3**

Last round **Series C**

Last round size **50M**

Last round date **Jan 2026**

## Funding filed with regulators

bit.bio filed 3 raises, $159M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Apr 2026 **$19M** UK share allotment
- Dec 2021 **$37M** UK share allotment
- Sept 2021 **$103M** UK share allotment

## Founders and team

From bit.bio's own website: 1 founder, 11 on the team.

**Mark Kotter** Founder bit.bio

- **Emma Pepperell** CEO
- **Sejla Salic-Hainzl** CTO
- **Adam Rowe** Head of Operations & Compliance
- **Connie O'Donnell** Head of Sales & Marketing
- **Kai Ling Gan** Head of Legal
- **Niv Pande** Head of Business Optimisation
- **Sam Jones** Head of Finance
- **Vicki Bell** Head of People & Culture
- **Cornel Chiriac** Board Member
- **Lord David Prior** Board Member
- **Milky Way** Board Member

Advisers *Altos Labs* *Anil Dhawan* *Katy Rezvani* *Loïc Vincent* *Marius Wernig*

## The company, in detail

What they build

Known for

health care human cell manufacturing systematic experimentation clinical translation of cells deterministic programming biotechnology research therapeutic candidates ipsc-derived cells distribution manufacturing immunocytochemistry cell therapy genetic screening toxicology studies scalable cell manufacturing pharmaceutical drug discovery

Built with from their website

Google Maps DocuSign Microsoft Power BI Google Tag Manager Hotjar Atlassian Flow Exclaimer Intel Nios Smartsheet

+8 more

Google Workspace Shopify Custom Zoom Meetings CloudFlare Workday Adaptive Planning Electron Viewport Meta HubSpot Content Hub

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 8731
- **Region:** England
- **Revenue:** 9M a year, as listed

## Research in United Kingdom

Startups like it

- [**Isomorphic Labs** London · founded 2021 *Raised*](https://millionrounds.com/company/isomorphic-labs)
- [**Basecamp Research** London · founded 2019 *Raised*](https://millionrounds.com/company/basecamp-research)
- [**Callosum** London · founded 2025 *Raised*](https://millionrounds.com/company/callosum)
- [**Artios** Babraham · founded 2016 *Raised*](https://millionrounds.com/company/artios)
- [**First Light Fusion** Yarnton · founded 2011 *Raised*](https://millionrounds.com/company/first-light-fusion)
- [**IMU Biosciences** London · founded 2019 *Raised*](https://millionrounds.com/company/imu-biosciences)
- [**Orbital Industries** London · founded 2022 *Raised*](https://millionrounds.com/company/orbital-industries)
- [**Genomics** Oxford · founded 2014 *Raised*](https://millionrounds.com/company/genomics)

## Is this your company?

Add your raise, your deck and your story, and put bit.bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)